Related references
Note: Only part of the references are listed.Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women
Laura Y. Park-Wyllie et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Estimating Bisphosphonate Use and Fracture Reduction Among US Women Aged 45 Years and Older, 2001-2008
Ethel S. Siris et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Living with a 'women's disease': risk appraisal and management among men with osteoporosis
Samantha L. Solimeo
JOURNAL OF MENS HEALTH (2011)
Secondary Prevention of Osteoporosis in Australia Analysis of Government-Dispensed Prescription Data
Samantha A. Hollingworth et al.
DRUGS & AGING (2010)
Changing Patterns in Medication Use with Increasing Probability of Death for Older Medicare Beneficiaries
Thomas Shaffer et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2010)
Missed opportunities for osteoporosis management in older patients: a literature review
Nishma Manek
Primary Health Care Research and Development (2010)
Osteoporosis in males and females: Is there really a difference?
Pascal Guggenbuhl
JOINT BONE SPINE (2009)
Management of osteoporosis in primary care in Australia
J. S. Chen et al.
OSTEOPOROSIS INTERNATIONAL (2009)
To stop or not to stop, that is the question
Ego Seeman
OSTEOPOROSIS INTERNATIONAL (2009)
Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study
B. A. Lenart et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture
Suzanne M. Cadarette et al.
ANNALS OF INTERNAL MEDICINE (2008)
Trends in HRT and anti-osteoporosis medication prescribing in a European population after the WHI study
L. Huot et al.
OSTEOPOROSIS INTERNATIONAL (2008)
The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study
A. Papaioannou et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis
CH Chesnut et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment
WP Olszynski et al.
CLINICAL THERAPEUTICS (2004)
Effect of risedronate on the risk of hip fracture in elderly women
MR McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Opinions and experiences in general practice on osteoporosis prevention, diagnosis and management
JC Taylor et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Hip fracture incidence rates in Singapore 1991-1998
LKH Koh et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Share Paper
